Technologies that make administration of vaccines safer

Vaccine

Volumn 22, Issue 15-16, 2004, Pages 2054-2058

  Clements, C John ^a   Larsen, Gordon ^a   Jodar, Luis ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Auto disable syringe; Immunisation; Jet gun; Jet injector; Multi dose vials; Oral polio vaccine (OPV); Oral nasal administration; Recapping; Reconstitution; Skin patch; Thiomersal; Trehelose; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; ANTIGEN; BCG VACCINE; HEPATITIS B VACCINE; INSULIN; MEASLES VACCINE; MUSCLE RELAXANT AGENT; PANCURONIUM BROMIDE; POLIOMYELITIS VACCINE; PRESERVATIVE; SUXAMETHONIUM; TETANUS TOXOID; THIOMERSAL; VACCINE;

CONFERENCE PAPER; DECISION MAKING; HEALTH CARE DELIVERY; HUMAN; IMMUNIZATION; JET INJECTION; LYMPHADENITIS; MATERIALS; NEEDLE; PARALYSIS; PERCEPTION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SYRINGE; TECHNOLOGY; TRAFFIC AND TRANSPORT; TRAINING;

DRUG COMPOUNDING; DRUG INDUSTRY; EXCIPIENTS; HUMANS; INJECTIONS; MEDICAL WASTE DISPOSAL; PRODUCT SURVEILLANCE, POSTMARKETING; TECHNOLOGY, PHARMACEUTICAL; TRANSPORTATION; VACCINATION; VACCINES;

EID: 2342617605     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.008     Document Type: Conference Paper

References (22)

1. Sood D.K., Kumar S., Singh S., Sokhey J. Measles vaccination in India and controversies regarding adverse reactions. Vaccine. 13:1995;785-786
2. Phadke M.A., Joshi B.N., Warerkar U.V., Diwan M.P., Panse G.A., Sokhey J., et al. Toxic shock syndrome: an unforseen complication following measles vaccination. Indian Pediatr. 28:1991;663-665
3. Vaccine supply and quality. Surveillance of adverse events following immunisation. Wkly Epidemol Rec 1996;71:237-42.
4. Hengster P., Schnapka J., Fille M., Menardi G. Occurrence of suppurative lymphadenitis after a change of BCG vaccine. Arch. Dis. Child. 67:1992;952-955
5. Kabra S.K., Jain Y., Seth M.V. BCG associated adenitis. Lancet. 341:1993;970
6. Noah P.K., Smickle M.F., Prabhakar P., Pande D., Jonhson B., Ashley D. Outbreak of Bacillus Calmette-Guérin associated lymphadenitis and abscesses in Jamaican children. Pediatr. Infect. Dis. 9:1990;890-893
7. Technet consultation. Geneva: World Health Organisation [WHO/EPI/LHIS/97.02 (available upon request from the Department of Vaccines and Biologicals, WHO, 1211 Geneva 27, Switzerland)].
8. State of the world's vaccines and immunisation. Geneva: World Health Organisation, United Nations Children's Fund; 1996. p. 159.
9. Kane A., Lloyd J., Zaffran M., Simonsen L., Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull. WHO. 77:1999;801-807
10. Hersh B.S., Popovici F., Apetrei R.C., Zolotusca L., Beldescu N., Calomfirescu A., et al. Acquired immunodeficiency syndrome in Romania. Lancet. 14(338):1991;645-649
11. Darwish M.A., Raouf T.A., Rushdy P., Constantine N.T., Rao M.R., Edelman R. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am. J. Trop. Med. Hyg. 49:1993;440-444
12. Farghaly A.G., Barakat R.M. Prevalence, impact and risk factors of hepatitis C infection. J. Egypt Public Health Assoc. 68:1993;63-79
13. Safety of injections. WHO-UNICEF policy statement of mass immunisation campaigns. Geneva: World Health Organisation; 1997 [unpublished document WHO/EPI/LHIS/97.04 available upon request from the Department of Vaccines and Biologicals, WHO, 1211 Geneva 27, Switzerland].
14. Steinglass R., Boyd D., Grabowsky M., Laghari A.G., Khan M.A., Qavi A., et al. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country. Bull WHO. 73:1995;57-63
15. Nelson C.M., Sutanto A., Suradana I.G. Use of SoloShot auto-destruct syringes compared with disposable syringes, in a national immunisation campaign in Indonesia. Bull WHO. 77:1999;29-33
16. The use of multi-dose vaccine vials in subsequent immunisation sessions. WHO policy statement. WHO/EPI/LHIS, October 1999.
17. Clements C.J., Ball L.K., Ball R., Pratt R.D. Thiomersal in vaccines - is removal necessary? Drug Saf. 24(8):2001;567-574
18. Canter J., Mackey K., Good L.S., Roberto R.R., Chin J., Bond W.W., et al. An outbreak of hepatitis B associated with jet injections at a weight reduction clinic. Arch. Intern. Med. 150:1990;1923-1927. [Hoffman PN]
19. Jódar L, Aguado T, Lloyd J, Lambert PH. Revolutionising immunisation. Genetic Engineering News, 15 February 1998.
20. Aguado T., Jódar L., Lloyd J., Lambert P.H. Injectable solid vaccines: a role in future immunisation? WHO Drug Inf. 12:1998;68-69
21. Brandtzaeg P. Basic mechanisms of mucosal immunity - a major adaptive defence system. Immunologist. 3:1995;89-96
22. Glenn G.M., Rao M., Matyas G.R., Alving C.R. Skin immunisation made possible by cholera toxin. Nature. 391:1998;851